Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections
Sponsor
Illinois Retina Associates (Other)
Overall Status
Completed
CT.gov ID
NCT00690313
Collaborator
Alcon Research (Industry)
22
1
2
32
0.7
Study Details
Study Description
Brief Summary
Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage.
In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 4 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
22 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
To Compare the Efficacy of Topical Vigamox Eye Drops at Tid 3 Days Prior to Intravitreal Injection Versus Tid 1 Day Prior to Intravitreal Injection
Study Start Date
:
Aug 1, 2008
Actual Primary Completion Date
:
Apr 1, 2011
Actual Study Completion Date
:
Apr 1, 2011
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Arm 1 Arm 1: receives Vigamox eye drops 3Xday for 3 days prior to intravitreal injection |
Drug: Vigamox
eye drops 3 times day either 1 or 3 days prior to intravitreal injection
|
| Active Comparator: Arm 2 Arm 2: receives Vigamox eye drops 3Xday for 1 day prior to intravitreal injection |
Drug: Vigamox
eye drops 3 times day either 1 or 3 days prior to intravitreal injection
|
Outcome Measures
Primary Outcome Measures
- Timed study [1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
21 Years
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patient who need intravitreal injections patients who are willing to participate in the study
Exclusion Criteria:
- Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Illinois Retina Associates | Harvey | Illinois | United States | 60426 |
Sponsors and Collaborators
- Illinois Retina Associates
- Alcon Research
Investigators
- Principal Investigator: Kourous A Rezaei, MD, Illinois Retina Associates SC
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Illinois Retina Associates
ClinicalTrials.gov Identifier:
NCT00690313
Other Study ID Numbers:
- Vig508
First Posted:
Jun 4, 2008
Last Update Posted:
Aug 7, 2019
Last Verified:
Aug 1, 2019
Keywords provided by Illinois Retina Associates
Additional relevant MeSH terms: